The benefits and pitfalls of patient-centric and patient-led trials.
Duncan Campbell & Gemma Rogers join writing specialists
Dynamic consent models for patients can develop ongoing partnership between participants and researchers.
Investors who see early-stage compounds and indications as valuable assets can support them to market.
Industry may be limiting its options if safety takes a back seat to efficacy in trial design and product development.
Data Integrity for Clinical Research Summit
Pharma Regulatory Summit
Extra funding will go toward the development of company’s NORA clinical trial platform.
Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?